Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease
暂无分享,去创建一个
A. Gastaldelli | E. Bugianesi | G. Saracco | D. Leeming | D. Ribaldone | M. Gaggini | G. P. Caviglia | C. Rosso | M. Abate | A. Olivero | M. Vernero | A. Armandi | A. Nicolosi | D. D’Amato | D. D'Amato | Marta Vernero
[1] E. Bugianesi,et al. Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease , 2021, Metabolites.
[2] Fang-Xiong Wu,et al. Circulating Irisin Levels in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis , 2020, Gastroenterology research and practice.
[3] Xiaoshuang Zhou,et al. Association between serum irisin concentrations and sarcopenia in patients with liver cirrhosis: a cross-sectional study , 2020, Scientific Reports.
[4] Anastasios Koulaouzidis,et al. Irisin in Liver Cirrhosis , 2020, Journal of clinical medicine.
[5] M. Karsdal,et al. Collagen Formation Assessed by N‐Terminal Propeptide of Type 3 Procollagen Is a Heritable Trait and Is Associated With Liver Fibrosis Assessed by Magnetic Resonance Elastography , 2019, Hepatology.
[6] M. Karsdal,et al. Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes , 2019, Diabetes Care.
[7] T. Berg,et al. A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR. , 2019, Journal of hepatology.
[8] R. Hultcrantz,et al. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. , 2017, Journal of hepatology.
[9] Kyu-Sang Park,et al. Circulating irisin levels as a predictive biomarker for sarcopenia: A cross‐sectional community‐based study , 2017, Geriatrics & gerontology international.
[10] G. Svegliati-Baroni,et al. Fibronectin Type III Domain–Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease , 2017, The Journal of clinical endocrinology and metabolism.
[11] J. Steinacker,et al. Association between circulating irisin and insulin resistance in non-diabetic adults: A meta-analysis. , 2016, Metabolism: clinical and experimental.
[12] M. Zou,et al. Irisin Is Regulated by CAR in Liver and Is a Mediator of Hepatic Glucose and Lipid Metabolism. , 2016, Molecular endocrinology.
[13] Weizhen Zhang,et al. Irisin Inhibits Hepatic Cholesterol Synthesis via AMPK-SREBP2 Signaling , 2016, EBioMedicine.
[14] Hai-Jian Sun,et al. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes. , 2015, Clinical science.
[15] J. Moreno-Navarrete,et al. Circulating Irisin Levels Are Positively Associated with Metabolic Risk Factors in Sedentary Subjects , 2015, PloS one.
[16] Ting Gao,et al. Circulating levels of irisin in middle-aged first-degree relatives of type 2 diabetes mellitus — correlation with pancreatic β-cell function , 2014, Diabetology & Metabolic Syndrome.
[17] C. Mantzoros,et al. The effect of Irisin on antioxidant system in liver. , 2014, Free radical biology & medicine.
[18] P. Vokonas,et al. Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events , 2014, International Journal of Obesity.
[19] Sungeun Kim,et al. Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans. , 2014, The Journal of clinical endocrinology and metabolism.
[20] C. Mantzoros,et al. Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans , 2014, International Journal of Obesity.
[21] D. Gašperíková,et al. Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies , 2014, The Journal of physiology.
[22] Zheng Chen,et al. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. , 2013, Journal of hepatology.
[23] J. Moreno-Navarrete,et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. , 2013, The Journal of clinical endocrinology and metabolism.
[24] B. Spiegelman,et al. A PGC1α-dependent myokine that drives browning of white fat and thermogenesis , 2012, Nature.
[25] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[26] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.